alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA Organization Charts

FDA Organization Charts Home
          About FDA
          FDA Organization
          FDA Organization Charts
          Center for Devices and Radiological Health Organization ChartFDA Organization Charts Center for Devices and Radiological Health Organization Chart
  
  	
    Share
    Post
    Linkedin

    Email
    PrintCDRH Leadership 2023 05 04

Text version of the above chart | Printer-friendly Version (PDF - 60KB)

Return to FDA Organization Charts

                                                                                  Content current as of:
      12/07/2023FDA Organization Charts
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BankFinancial Corporation (the
Company) on Form 10-Q for the period ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Paul A. Cloutier, Executive Vice President and Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
the Company.



|                                                     |  |  |  |                        
|---------------------------------------------------- |  |  |  | -----------------------
|/s/    PAUL A. CLOUTIER                              |  |  |  | Dated: October 27, 2009
|Paul A. Cloutier                                     |  |  |  |                        
|Executive Vice President and Chief Financial Officer |  | 

A signed original of this written statement required by Section 906 has been provided to
BankFinancial Corporation and will be retained by BankFinancial Corporation and furnished to the Securities and Exchange Commission or its staff upon request.



46
[PROPOSED] ORDER GRANTING FINJAN’S CASE NO. 5:17-cv-00072-BLF-SVK 

MOTION TO WITHDRAW AS COUNSEL 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

PAUL ANDRE (SBN 196585) 

pandre@kramerlevin.com 

LISA KOBIALKA (SBN 191404) 

lkobialka@kramerlevin.com 

JAMES HANNAH (SBN 237978) 

jhannah@kramerlevin.com 

HANNAH LEE (SBN 253197) 

hlee@kramerlevin.com 

BENU WELLS (pro hac vice) 

bwells@kramerlevin.com 

KRAMER LEVIN NAFTALIS 

& FRANKEL LLP 

990 Marsh Road 

Menlo Park, CA 94025 

Telephone: (650) 752-1700 

Facsimile: (650) 752-1800 

Attorneys for Plaintiff 

FINJAN, INC. 

IN THE UNITED STATES DISTRICT COURT 

FOR THE NORTHERN DISTRICT OF CALIFORNIA 

SAN JOSE DIVISION 

FINJAN, INC., a Delaware Corporation, 

Plaintiff, 

v. 

CISCO SYSTEMS, INC., a California 

Corporation, 

Defendant. 

Case No. 5:17-cv-00072-BLF-SVK 

[PROPOSED] ORDER GRANTING 

PLAINTIFF FINJAN, INC.’S UNOPPOSED 

MOTION TO WITHDRAW AND 

SUBSTITUTE COUNSEL 

Case 5:17-cv-00072-BLF Document 521 Filed 04/15/20 Page 1 of 2
1 

[PROPOSED] ORDER GRANTING FINJAN’S CASE NO. 5:17-cv-00072-BLF-SVK 

MOTION TO WITHDRAW AS COUNSEL 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Having reviewed and considered the Plaintiff Finjan, Inc.’s Motion for Order 

Permitting Withdrawal and Substitution of Counsel, and good cause appearing, the Court hereby 

orders that Paul Andre, Lisa Kobialka, James Hannah, Kristopher Kastens, Hannah Lee, Benu Wells, 

Cristina Martinez, Phuong Nguyen, Shannon Hedvat, Hien Lien, Yuridia Caire, Gregory Proctor, 

Daniel Williams, Melissa Brenner, Austin Manes and Aaron Frankel of Kramer Levin Naftalis & 

Frankel LLP be permitted to withdraw as counsel of record, and Roger Denning, Juanita Brooks, Frank 

Albert, Nicole Williams, Oliver Richards, Jared Smith, Alana Mannige, Megan Chacon and Aamir 

Kazi of Fish & Richardson P.C., may be substituted as counsel of record for Finjan, Inc. The Court’s 

ECF system shall be updated to reflect these changes. 

IT IS SO ORDERED. 

Date: ________________, 2020 ________________________________________ 

Judge Beth Labson Freeman 

United States District Court Judge 

April 15

Case 5:17-cv-00072-BLF Document 521 Filed 04/15/20 Page 2 of 2
Independent Auditors' Consent

The Board of Directors
Champps Entertainment, Inc.:

We consent to the incorporation by reference in the registration statements
Nos. 333-32501, 333-32503, and 333-90287 on Forms S-8 of Champps Entertainment,
Inc. of our report dated August 26, 2002, with respect to the consolidated
balance sheets of Champps Entertainment, Inc. as of June 30, 2002 and July 1,
2001, and the related consolidated statements of operations, changes in
shareholders' equity and cash flows for each of the years in the three-year
period ended June 30, 2002, which report appears in the June 30, 2002, annual
report on Form 10-K of Champps Entertainment, Inc.

KPMG LLP


Denver, Colorado
September 26, 2002
Brandi JENKINS, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-2706

District Court of Appeal of Florida, Fifth District.

Opinion filed May 31, 2019

James S. Purdy, Public Defender, and Kevin R. Holtz, Assistant Public Defender, Daytona Beach, for Appellant.

Ashley Moody, Attorney General, Tallahassee, and Lori N. Hagan, Assistant Attorney General, Daytona Beach, for Appellee.

PER CURIAM.

Following a nonjury trial, the defendant, Brandi Jenkins, was found by the court to have willfully and materially violated the terms of her community control. Jenkins had previously received a five-year prison sentence for burglary of a conveyance and a consecutive two-year prison sentence for felony petit theft, with both sentences suspended *876conditioned upon Jenkins successfully completing her community control. The trial court revoked Jenkins's community control and sentenced her to serve the full suspended sentence.

Jenkins's sole argument on appeal is that the trial court failed to understand that it had the discretion not to impose the entire suspended sentence once it revoked her community control. Jenkins is correct that a suspended sentence merely acts as a cap on the sentencing court, and it is not required to impose the suspended sentence in the event of a violation of community control or probation. *See**Harvey v. State* , 156 So. 3d 583, 585 (Fla. 5th DCA 2015). The court retains the discretion and authority to impose any sentence that it could otherwise have imposed. *Id.*

Subsequently to filing her notice of appeal, Jenkins filed a motion under Florida Rule of Criminal Procedure 3.800(b)(2), asserting that the trial court had committed an error in sentencing by failing to recognize its discretion to impose a sentence that was less than the aggregate seven-year suspended sentence. In timely denying the motion, the court acknowledged Jenkins's argument and its discretion in sentencing, but it nevertheless declined to reconsider and modify the sentence. Thus, because it appears that the trial court was aware of its authority and discretion to have imposed less than the full suspended sentence, but simply declined to do so, we affirm the order revoking community control and the resulting judgment and sentence.

AFFIRMED.

LAMBERT, EISNAUGLE and HARRIS, JJ., concur.
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

UNIONAMERICA INSURANCE CO.,

LIMITED, Successor-ininterest to ST. PAUL

REINSURANCE,

Plaintiff(s),

v.

THE FORT MILLER GROUP, INC.,

THE FORT MILLER CO. and

BEECHE SYSTEMS CORP.,

Defendant(s).

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

No. C05-1912 BZ

JUDGMENT

This action came on for trial before the Court on

February 23, 2009. The issues having been duly tried and

Findings of Fact and Conclusions of Law having been duly

rendered, IT IS ORDERED, ADJUDGED and DECREED that plaintiff,

Unionamerica Insurance Company, is entitled to rescission of

the 2000 and 2001 CGL gap policies and to reimbursement in

the amount of $1,548,292.32, with interest and costs as

permitted by law. 

The Court having granted Unionamerica’s motion to

Case 3:05-cv-01912-BZ Document 355 Filed 03/16/09 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

dismiss the counterclaim, IT IS FURTHER ORDERED, ADJUDGED AND

DECREED that the First Amended Counterclaim is dismissed on

the merits and that Unionamerica recover its costs as

permitted by law. 

Dated: March 16, 2009

 

 Bernard Zimmerman

 United States Magistrate Judge

G:\BZALL\-BZCASES\UNIONAMERICA V. FORT MILLER\TRIAL\JUDGMENT.FINAL VERSION.BZ.wpd

Case 3:05-cv-01912-BZ Document 355 Filed 03/16/09 Page 2 of 2
# m8717.docx

EUROPEAN COMMISSION Brussels, 15.12.2017 C(2017) 8906 To the Notifying Party Subject : Case M. 8717 – ENGIE / IPM ENERGY TRADING / INTERNATIONAL POWER FUEL COMPANY Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 23 November 2017 , the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which Engie S.A. (" Engie ", France) indirectly acquire s within the meaning of Article 3(1)(b ) of the Merger Regulation sole control over the whole of the undertaking s IPM Energy Trading Limited ("IPMETL", the UK), contr olled by Engie (France) and Mitsui Co ., Ltd (Japan) , and International Power Fuel Company Limited ("IPFC", the UK), controlled by Engie (France) and Mitsui Co. , Ltd. (Japan) by way of purchase of shares . 3 2. The business activities of the undertakings concerned are: - for Engie : global energy player active across the entire energy value chain in the fields of gas, electricity and energy services, - for IPMETL: providing energy trading services to the wholesale gas and electricity markets in Great Britain, - for IPFC: providing natural gas shipping services in Great Britain. 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 ( d ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1 )( b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission (Signed) Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 406 , 30.11.2017 , p. 3 .
(4)
OJ C 366, 14.12.2013, p. 5 .
GEICO GENERAL INSURANCE COMPANY, Appellant/Petitioner(s), v. Sherol ZIEGENBEIN, et al., Appellee/Respondent(s).

CASE NO.: 2D19-1486

District Court of Appeal of Florida, Second District.

May 23, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Granted. Appeal is dismissed.
Courtney BENTLEY, Appellant, v. STATE of Florida, Appellee.

No. 1D18-2551

District Court of Appeal of Florida, First District.

May 29, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Arnaldo LUGO-FERNANDEZ, Appellant, v. The STATE of Florida, Appellee.

No. 3D18-1263

District Court of Appeal of Florida, Third District.

Opinion filed February 20, 2019.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 99.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002



In connection with the Quarterly Report
of Harbor Global Company Ltd. (the Company) on Form 10-Q for the period ending March 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Donald H. Hunter, Chief Financial Officer
of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



(1) The Report fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934;
and



(2) The information contained in the Report
fairly presents, in all material respects, the financial condition and result of operations of the Company.



Dated: May 6, 2003



/s/    DONALD H. HUNTERDonald H. Hunter Chief Financial Officer




This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.
Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Health Fraud Scams

Health Fraud Scams

                        El Fraude en la Salud Home
          For Consumers
          Health Fraud Scams
          Health Fraud Scams - Weight LossHealth Fraud Scams Health Fraud Scams - Weight Loss
  
  	
    Share
    Post
    Linkedin

    Email
    Print

                                                                                  Content current as of:
      01/16/2018Health Fraud Scams

          
                        El Fraude en la Salud
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop
CX8267 

Case 5:17-cv-00220-LHK Document 1311-3 Filed 01/14/19 Page 1 of 2
From: Blecker, Marv

To: Jacobs Paul; Jha, Sanjay; Mollenkopf, Steven; Jacobs, Jeff

CC: exo; Aberle, Derek Hartogs, Mike

Sent: 2/22/2008 3:05:19 PM

Subject: Re: RIM MFN and MDF

At 10:53 PM2/21/2008, Jacábs, Paul wrote:

During dinner. RIM asked about.sonie kind of MFN for chips 1 told thenithat it woulddt guamntee themthe same pricing because they

dodthav the same volumes as tlie bigger customers, but diey would stil11ikä some kind of assurance for simihirly situated customers. I

assume this is a reasonable thing to do foi thent Mike Lazaridis is tle contact for this

Thëy are very focused on taking the slotincúrrier litie ups that was previously bekl by Motorola and thus growing their volumes

draalatically They see Nokia as their key competitor. and wouldlike to structuit some carrier focused marketing prograins as welL

Given the price point of their products and the size of the associated rovaltv. we should look.hard at how we can coiltÑbute to them taking

share from Nokia, Jün Basilie would be the contact. and a shoukl work witlihitit

While f don't disagree with your sentiment regarding taking share from Nokia, you shouki keep in mind that the

positions they have taken in their lawsuit against Motorola wrt FRAND and their positions in ETSI and elsewhere

havebeen diametrically opposed to our positions and our business modeL

Paul

This nussage (including any attachments}is litended only for the use of the addressee(s) naned above. It inay contain information that is

LEGAI1Y PRIVILEGED and CONFIDENTIAL and should not be read. copied or otherwise used by any other person If you are not the

intended recipient, you are liereby notified that anruse, retention, disclosure, copying, printing fordarding or disseminaticitof this

comumnication is sitietly prohibited, If you have received this communication inetror please erase all copies of the message and its

attachnents and notify us immedigely.

Marv Blecker

(858) 658-4210

(858) 651 1975 (fax)

£rhibitNa;

Paul Jacobs

18 Aoril 2018 /

huryAPakeco/¿3⁄4iarsRNo.77DS

HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY QAPPCÑ\SDOO432506

CX8267-001

Case 5:17-cv-00220-LHK Document 1311-3 Filed 01/14/19 Page 2 of 2
**EXHIBIT 31.2**

**CERTIFICATIONS**

I, Craig R. Ramsey,certify that:

1.                 I have reviewedthis quarterly report on Form 10-Q of Marquee Holdings Inc.;

2.                 Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.                 Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.                 The registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

a)               Designed suchdisclosure controls and procedures, or caused such disclosure controls and proceduresto be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period inwhich this report is being prepared;

b)              Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c)               Disclosed in thisreport any change in the registrant’s internal control over financial reportingthat occurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonable likely to materially affect, the registrant’sinternal control over financial reporting; and

5.                 The registrant’sother certifying officer and I have disclosed, based on our most recent evaluationof internal control over financial reporting, to the registrant’s auditors andthe audit committee of registrant’s board of directors (or persons performingthe equivalent functions):

a)               All significant deficienciesand material weaknesses in the design or operation of internal control overfinancial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financialinformation; and

b)              Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.
| Date: February 14, 2007 | /s/ CRAIG R.  RAMSEY                                  |
|------------------------------|-------------------------------------------------------|
|                         | Craig R. Ramsey                                       |
|                         | Executive Vice President and  Chief Financial Officer |

 

53

----
Case 3:17-cv-00223-RS   Document 145   Filed 05/26/17   Page 1 of 1
Terashey Marie MERRITT, Appellant, v. Christopher MERRITT, Appellee.

No. 1D18-4776

District Court of Appeal of Florida, First District.

June 20, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.